Disorders of immune dysregulation
Gene: STXBP2
PMID 25564401: four unrelated families (P1‑P4) harbouring heterozygous (monoallelic) or biallelic STXBP2 miss‑sense variants at codon 65 (R65Q or R65W) that cause familial haemophagocytic lymphohistiocytosis (F‑HLH). Functional assays (patient CTL/NK cytotoxicity, degranulation, forced expression in control cells, liposome‑fusion assays) demonstrate that the R65Q/W mutants act in a dominant‑negative manner to inhibit SNARE‑complex assembly and membrane fusion. Two families carry heterozygous variants (monoallelic disease) and two families carry biallelic variants (homozygous R65Q or compound‑heterozygous R65Q + G541S).
Insufficient evidence for monoallelic MOI except for variants at this specific codon.Created: 13 Aug 2026, 2:34 p.m. | Last Modified: 13 Aug 2026, 2:34 p.m.
Panel Version: 2.8
Well established gene-disease association.Created: 23 Mar 2022, 4:22 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Haemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease 613101
Publications
Publications for gene: STXBP2 were set to 19804848
Gene: stxbp2 has been classified as Green List (High Evidence).
Phenotypes for gene: STXBP2 were changed from to Haemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease MIM#613101
Publications for gene: STXBP2 were set to
Mode of inheritance for gene: STXBP2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: STXBP2 was added gene: STXBP2 was added to Disorders of immune dysregulation_MGHA_AGHA_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: STXBP2 was set to Unknown